Measurement of glycine binding site of N‐methyl‐d‐asparate receptors in living human brain using 4‐acetoxy derivative of L‐703,717, 4‐acetoxy‐7‐chloro‐3‐[3‐(4‐[11c] methoxybenzyl) phenyl]‐2(1H)‐quinolone (AcL703) with positron emission tomography

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Synapse

• Publication date

  2007-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/syn.20415PMID 17598152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET.

  2006cited by this paper
• Long-term potentiation of synaptic transmission at the mossy fiber-granule cell relay of cerebellum.

  2005cited by this paper
• The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

  2004cited by this paper
• Radiation dosimetry estimates for the PET serotonin transporter probe 11C-DASB determined from whole-body imaging in non-human primates

  2004cited by this paper
• Effects of endogenous agonists, glycine and D‐serine, on in vivo specific binding of [11C]L‐703,717, a PET radioligand for the glycine‐binding site of NMDA receptors

  2003cited by this paper
• Impact of aging on hippocampal function: plasticity, network dynamics, and cognition.

  2003cited by this paper
• Regional distribution of human cerebral vascular mean transit time measured by positron emission tomography

  2003cited by this paper
• Imaging the PCP site of the NMDA ion channel.

  2002cited by this paper
• In vivo evaluation of [11C]-3-[2-[(3-methoxyphenylamino)carbonyl]ethenyl]-4,6-dichloroindole-2-carboxylic acid ([11C]3MPICA) as a PET radiotracer for the glycine site of the NMDA ion channel.

  2002cited by this paper
• A positron‐emitter labeled glycineB site antagonist, [11C]L‐703,717, preferentially binds to a cerebellar NMDA receptor subtype consisting of GluR ϵ3 subunit in vivo, but not in vitro

  2002cited by this paper
• A prodrug of NMDA/glycine site antagonist, L-703,717, with improved BBB permeability: 4-acetoxy derivative and its positron-emitter labeled analog.

  2001influential reference
• A strategy for increasing the brain uptake of a radioligand in animals: use of a drug that inhibits plasma protein binding.

  2000influential reference
• An improved synthesis of [11C]L-703,717 as a radioligand for the glycine site of the NMDA receptor.

  1999cited by this paper
• CHAPTER 45 - Preliminary Evaluation of the Glycine Site Antagonists [ 11 C]L 703,717 and [ 3 H]MDL 105,519 as Putative PET Ligands for Central NMDA Receptors: In Vivo Studies in Rats

  1998influential reference
• Distribution and expression of the subunits of N-methyl-D-aspartate (NMDA) receptors; NR1, NR2A and NR2B in hypoxic newborn piglet brains.

  1998cited by this paper
• Synthesis and in vivo evaluation of 7-chloro-5-[123I]iodo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid.

  1997cited by this paper
• A synaptic basis for memory storage in the cerebral cortex.

  1996cited by this paper
• Cloning of the cDNA for the human NMDA receptor NR2C subunit and its expression in the central nervous system and periphery.

  1996influential reference
• NMDA receptor expression in the mouse cerebellar cortex

  1995cited by this paper
• Regional cerebral blood flow, blood volume, oxygen extraction fraction, and oxygen utilization rate in normal volunteers measured by the autoradiographic technique and the single breath inhalation method

  1995cited by this paper
• Cloning, Functional Coexpression, and Pharmacological Characterisation of Human cDNAs Encoding NMDA Receptor NR1 and NR2A Subunits

  1994cited by this paper
• Statistical parametric maps in functional imaging: A general linear approach

  1994cited by this paper
• 3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor.

  1994cited by this paper
• N-methyl-D-aspartic acid receptor structure and function.

  1994cited by this paper
• Empirical Relationships between Need for Cognition and Cognitive Style: Implications for Consumer Psychology

  1994cited by this paper
• Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.

  1993cited by this paper
• Molecular diversity of the NMDA receptor channel

  1992cited by this paper
• Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs

  1992cited by this paper
• Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes

  1992cited by this paper
• Molecular cloning and characterization of the rat NMDA receptor

  1991cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991cited by this paper
• Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age.

  1990cited by this paper
• An in vivo evaluation

  1989cited by this paper
• Reduction in regional cerebral metabolic rate of oxygen during human aging.

  1986cited by this paper

• New advances in small molecule drugs targeting NMDA receptors

  2025cites this paper
• Glutamate’s Effects on the N-Methyl-D-Aspartate (NMDA) Receptor Ion Channel in Alzheimer’s Disease Brain: Challenges for PET Radiotracer Development for Imaging the NMDA Ion Channel

  2023cites this paper
• Development of PET and SPECT Radioligands for In Vivo Imaging of NMDA Receptors

  2020cites this paper
• Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors.

  2018cites this paper
• PET in Neurological and Psychiatric Disorders: Technologic Advances and Clinical Applications

  2017cites this paper
• Development of PET and SPECT Probes for Glutamate Receptors

  2015cites this paper
• Development of 18 F-labeled radiotracers for neuroreceptor imaging with positron emission tomography

  2014cites this paper
• Initial Evaluation of 18F-GE-179, a Putative PET Tracer for Activated N-Methyl d-Aspartate Receptors

  2014cites this paper
• Initial Evaluation of 18 F-GE-179 , A Putative PET Tracer for Activated N-Methyl D-Aspartate Receptors

  2014cites this paper
• Development of 18F-labeled radiotracers for neuroreceptor imaging with positron emission tomography

  2014cites this paper
• Development of Radioligands for In Vivo Imaging of NMDA Receptors

  2014cites this paper
• Radiosynthesis of carbon-11 and fluorine-18 labelled radiotracers to image the ionotropic and metabotropic glutamate receptors.

  2013cites this paper
• PET and SPECT tracers for glutamate receptors.

  2013cites this paper
• Preliminary studies of (99m)Tc-memantine derivatives for NMDA receptor imaging.

  2012cites this paper
• The glutamate hypothesis of schizophrenia: neuroimaging and drug development.

  2012cites this paper
• What have positron emission tomography and ‘Zippy’ told us about the neuropharmacology of drug addiction?

  2011cites this paper
• Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists

  2011cites this paper
• PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development.

  2010cites this paper
• For Peer Review Spontaneous rapid resolution of acute Basal Ganglia changes in an untreated infant with Propionic Acidemia: A clue to pathogenesis ?

  2010cites this paper
• In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models.

  2010cites this paper
• The application of PET technique for the development and evaluation of novel antipsychotics.

  2010cites this paper
• Synthesis and biological evaluation of radio-iodinated benzimidazoles as SPECT imaging agents for NR2B subtype of NMDA receptor.

  2010cites this paper
• Spontaneous Rapid Resolution of Acute Basal Ganglia Changes in an Untreated Infant with Propionic Acidemia: A Clue to Pathogenesis?

  2010cites this paper
• Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors.

  2009cites this paper
• Fundamental studies on radiotracers intended for receptor imaging in dementia

  2008cites this paper
• Difference in brain distributions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel.

  2008cites this paper